Publications by authors named "A Benamor"
Article Synopsis
- * Real-world data shows that many patients continue to experience controlled disease activity for several years after the initial treatment, even though the official guidance does not extend beyond this period.
- * A group of expert neurologists provides recommendations on how to start and switch to CladT, manage treatment during the first two years, and handle ongoing care in later years to optimize treatment benefits and limit MS progression.
This paper proposes a novel robust tracking control scheme for discrete time linear uncertain Multiple-Input Multiple-Output (MIMO) systems subject to time-varying delay on the states. The considered system is affected by unknown but norm bounded uncertainties on parameters as well as matched disturbances on the states. The designed controller is based upon a proposed novel integral sliding surface and a new switching type of reaching law.
View Article and Find Full Text PDFArticle Synopsis
- * Serious side effects like extreme lymphopenia are rare, but monitoring for infections and screening for liver function are recommended before starting CladT treatment.
- * The risk of developing malignancies with CladT is similar to general population rates and other treatments, and overall, CladT is considered to have a good safety profile for RMS management.
Decorating nanomaterials on graphene oxide (GO) can enhance its adsorption capacity and removal efficiency of water pollutants. In this study, for the first time, nano-sized polylactic acid (PLA) has been successfully decorated on the surface of GO through a facile synthesis approach. The adsorptive efficiency of GO-PLA for removing methylene blue (MB) and tetracycline (TC) from an aqueous solution was examined.
View Article and Find Full Text PDF